Research Analysts Issue Forecasts for U.S. Physical Therapy, Inc.'s FY2025 Earnings (NYSE:USPH)

U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) - Analysts at Barrington Research lowered their FY2025 EPS estimates for U.S. Physical Therapy in a report released on Wednesday, October 9th. Barrington Research analyst M. Petusky now expects that the company will post earnings of $2.50 per share for the year, down from their previous estimate of $2.85. Barrington Research has a "Outperform" rating and a $108.00 price objective on the stock. The consensus estimate for U.S. Physical Therapy's current full-year earnings is $2.47 per share. Barrington Research also issued estimates for U.S. Physical Therapy's FY2026 earnings at $2.85 EPS.

A number of other equities analysts also recently weighed in on USPH. StockNews.com upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Wednesday, August 21st. Bank of America reiterated a "neutral" rating and issued a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday.

U.S. Physical Therapy Stock Up 3.6 %

NYSE:USPH traded up $2.80 during trading hours on Friday, hitting $80.32. 161,223 shares of the company's stock traded hands, compared to its average volume of 89,307. The stock's fifty day moving average price is $84.09 and its two-hundred day moving average price is $94.40. The firm has a market cap of $1.21 billion, a P/E ratio of 75.77, a P/E/G ratio of 3.16 and a beta of 1.39. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. U.S. Physical Therapy has a twelve month low of $76.18 and a twelve month high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). The firm had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. U.S. Physical Therapy's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm earned $0.76 earnings per share.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 23rd were paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date was Friday, August 23rd. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 166.04%.

Insider Activity

In other news, COO Graham D. Reeve sold 1,724 shares of the firm's stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Kathleen A. Gilmartin purchased 2,000 shares of the stock in a transaction on Tuesday, September 3rd. The shares were bought at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares in the company, valued at approximately $1,627,445.36. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Graham D. Reeve sold 1,724 shares of the business's stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares of the company's stock, valued at $580,635. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Several large investors have recently made changes to their positions in USPH. Creative Planning bought a new position in U.S. Physical Therapy in the 3rd quarter worth approximately $252,000. Martin Capital Advisors LLP increased its position in U.S. Physical Therapy by 1.6% during the third quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company's stock worth $1,112,000 after acquiring an additional 201 shares during the period. True North Advisors LLC raised its stake in U.S. Physical Therapy by 22.5% during the 3rd quarter. True North Advisors LLC now owns 7,826 shares of the company's stock valued at $662,000 after purchasing an additional 1,438 shares during the last quarter. Handelsbanken Fonder AB boosted its holdings in U.S. Physical Therapy by 25.0% in the 3rd quarter. Handelsbanken Fonder AB now owns 3,000 shares of the company's stock valued at $254,000 after purchasing an additional 600 shares during the period. Finally, Truist Financial Corp grew its position in U.S. Physical Therapy by 9.2% in the 2nd quarter. Truist Financial Corp now owns 10,382 shares of the company's stock worth $960,000 after purchasing an additional 874 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.